Jeffrey Teply, MD
Obstetrics · Topeka, KSNPI 1558307264
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $403 and has fallen 57.2% since, to $172 in 2025.
Across 63 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$188
- Biogen$145
- Medtronic$129
- Hologic Sales And Service, LLC$84
- Organon$79
- Bayer$65
- plus $516 from 18 others
What the payments were for
- Food & beverage$1,17397%
- Education$333%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $188 |
| Biogen | 6 | $145 |
| Medtronic | 3 | $129 |
| Hologic Sales And Service, LLC | 5 | $84 |
| Organon | 4 | $79 |
| Bayer | 4 | $65 |
| Merck | 3 | $53 |
| Axonics, Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Covidien LP | 3 | $42 |
| Millicent US Inc | 2 | $40 |
| Pfizer | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| Exeltis, USA Inc. | 2 | $31 |
| Therapeuticsmd, Inc. | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Coopersurgical, Inc. | 1 | $18 |
| Gynesonics, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
Too few obstetrics providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics in Topeka
- Jessica KiefferTopeka$3K
- Traci NauserOverland Park$5K
- Jennifer LitwinOlathe$4K
- James WhiddonWichita$3K
- Leslie AblardSalina$2K
- Matthew VothWichita$491
- Ericka DomalakesMerriam$60
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.